Apollo Hospitals Enterprise reported a strong Q2FY26 with a 26% YoY rise in profit after tax to Rs 477 crore, driven by broad-based growth across healthcare, diagnostics, and digital verticals. Consolidated revenue increased 13% to Rs 6,304 crore, supported by steady patient volumes and margin improvements.
Astral shares drop 6% after demerger. What should investors do?
Astral shares fell nearly 6% on Monday after the company’s board approved the demerger of its chemicals business into a newly incorporated entity, Astral Chemie.